Pulmonx
Scott Bauer is an experienced sales professional currently serving as a Territory Manager at Pulmonx Corporation since April 2021. Prior to this role, Scott held the position of Sales Director at Inform Diagnostics from January 2020 to April 2021. From April 2010 to October 2019, Scott worked as a Senior Territory Sales Consultant at BD and served as Sr. Territory Manager at Mölnlycke Health Care DACH between May 2004 and May 2010. Scott began a career in sales at MCI, where responsibilities spanned from 2000 to 2004. Scott holds a Bachelor's degree in Sport Management from the University of Massachusetts Amherst.
This person is not in any teams
This person is not in any offices
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1